On September 15, 2026, Norges Bank sold 171,900 shares of TIGERMED (03347) on the SEHK open market at an average of HKD 43.7462 per share, involving about HKD 7.52 million, an on-exchange active trade representing a direct secondary-market dealing.
Prior to the disposal, Norges Bank's long position in TIGERMED was 7.40 million shares, representing 6.01%; following the disposal, the holding changed to 7.23 million shares, with the long position ratio falling to 5.87%.